Nexalin Technology, Inc. — Director's Dealing 2025

Feb 10, 2025

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Nexalin Technology, Inc. (NXL)
CIK: 0001527352
Period of Report: 2024-12-31

Reporting Person: Shelton Carolyn Hamby (Senior VP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-14	Common stock	P	24000	$0.85	Acquired	24000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-07	Stock Option (right to buy)	$0.6621	A	90620	Acquired	2029-09-25	Common Stock (90620)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	24000	Direct

Footnotes

F1: Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs.

F2: The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027.